Do ARKG and BBH hold the same stocks?

By their latest filings, 12% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, ARKG or BBH?

ARKG has 5% of its weight in S&P 500 names and BBH has 64%, so BBH differs more from the index.

Which is cheaper, ARKG or BBH?

ARKG charges 0.75% a year and BBH charges 0.35%, so BBH is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

ARKG vs BBH: Holdings Overlap & Returns

Share on X Download as PDF

Over the year to Nov 4, 2026, ARKG returned +68.4% to BBH's +47.2%; 12% of their weight is in the same names.

askIQ about this page

askIQ about ARKG and BBH

Net assets: $2.1bn on Nov 2, 2026 for ARK Genomic Revolution ETF, and $525m on Nov 3, 2026 for VanEck Biotech ETF.

ARKG on its own →BBH on its own →

At a glance

4.6%

ARKG in the S&P 500

64.4%

BBH in the S&P 500

+68.4%

ARKG total return, 1 year

+47.2%

BBH total return, 1 year

ARKG · 1 year to Nov 4, 2026 95% of its weight is outside the S&P 500

5% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.

BBH · 1 year to Nov 4, 2026 36% of its weight is outside the S&P 500

64% of BBH's weight is in S&P 500 companies and 36% is outside the index. Holdings as of Nov 2, 2026.

Pair scorecard

BBH costs 0.40 points a year less; their one-year returns differ by 21.2 points; ARKG is 4.0 times larger.

ARKG vs BBH: Holdings Overlap & Returns
Measure	ARKG	BBH
Return
Measure	ARKG	BBH
Total return, 1 year	+68.4%	+47.2%
Drawdown
Measure	ARKG	BBH
Below its all-time high	55.5%, high on Jan 20, 2021
Benchmark
Measure	ARKG	BBH
What it tracks	Genomics and gene editing	Biotech
Cost and size
Measure	ARKG	BBH
Expense ratio	0.75%	0.35%
Net assets, as of Nov 2, 2026	$2.1bn	$524m
Active share vs the S&P 500	98%	99%
Holdings
Measure	ARKG	BBH
Holdings in common	12%
Top ten holdings, share of the fund	58%	74%

Method

Risk and return

Nov 7, 2014 to Oct 30, 2026 · 625 weekly returns

ARKG BBH

Return

Total return edge ARKG +179.6% +136.3%

Annualized edge ARKG +8.9% +7.4%

Price return edge ARKG +161.6% +125.4%

Risk

Volatility edge BBH 39.8% 22.7%

Max drawdown edge BBH −82.9% −37.7%

Risk-adjusted

Sharpe edge ARKG (slight) 0.36 0.34

Sortino edge ARKG 0.55 0.49

Calmar edge BBH 0.11 0.20

Reading

From Nov 2014 to Oct 2026, ARKG returned more: +179.6% to +136.3%. BBH swung less: 22.7% to 39.8%. BBH fell less at its worst: −37.7% to −82.9%.

Full scorecard

9 measures, with how each is measured Open ↓

Risk and return: ARKG vs BBH: Holdings Overlap & Returns
Measure	ARKG	BBH	Edge	How it is measured
Return
Total return	+179.6%	+136.3%	ARKG	Price change plus distributions, reinvested.
Annualized	+8.9%	+7.4%	ARKG	Total return as a yearly rate.
Price return	+161.6%	+125.4%	ARKG	Price change alone, distributions left out.
Risk
Volatility	39.8%	22.7%	BBH	Spread of weekly returns, annualized. Lower is steadier.
Downside deviation	26.2%	15.7%	BBH	Like volatility, counting only weeks below the Treasury bill rate.
Max drawdown	−82.9%	−37.7%	BBH	Deepest fall from a high to the low after it.
Risk-adjusted
Sharpe	0.36	0.34	ARKG (slight)	Return above Treasury bills per unit of volatility.
Sortino	0.55	0.49	ARKG	Return above Treasury bills per unit of downside deviation.
Calmar	0.11	0.20	BBH	Annualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 625 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

12%

By the books each fund has filed, ARKG and BBH hold 12% of their money in the same securities at the same weight. Holdings dated Nov 2, 2026 and Nov 3, 2026.

50%

0 half 100%

half

12% in common

Positions both hold · largest shared weight first ARKG BBH

NATERA INC 4.67% 4.44%

ILLUMINA INC 4.26% 3.37%

GUARDANT HEALTH INC 5.13% 2.83%

TEMPUS AI INC-CL A 9.85% 1.01%

Only in one fund ↓

Only in ARKG

10X GENOMICS INC-CLASS A 7.52%

TWIST BIOSCIENCE CORP 7.42%

CRISPR THERAPEUTICS AG 5.48%

ABSCI CORP 5.08%

ELI LILLY & CO 4.59%

CAREDX INC 4.50%

BEAM THERAPEUTICS INC 3.84%

VERACYTE INC 3.80%

Only in BBH

Amgen Inc 16.53%

Gilead Sciences Inc 14.17%

Regeneron Pharmaceuticals Inc 7.99%

Vertex Pharmaceuticals Inc 7.98%

Moderna Inc 6.88%

Iqvia Holdings Inc 4.18%

Argenx Se 4.13%

Revolution Medicines Inc 3.82%

Check overlap with more funds →

Window by window

Window by window: ARKG vs BBH: Holdings Overlap & Returns
	Total return
Window	ARKG	BBH
3 months	+20.5%	+24.3%
6 months	+60.0%	+38.3%
1 year	+68.4%	+47.2%
3 years	+90.8%	+75.4%
Since launchNot the same days: ARKG Oct 2014 · BBH Dec 2011	+164.2%	+680.5%

Open this comparison in the app →

Side by side

ARKG ARK Genomic Revolution ETF · Holds 35 stocks in genomics and gene editing, 5% of its weight in S&P 500 companies BBH VanEck Biotech ETF · Holds 25 stocks in biotech, 64% of its weight in S&P 500 companies

Issuer ARK VanEck

Theme Genomics and gene editing Biotech

In the S&P 500 4.6% 64.4%

Active share vs the S&P 500 98.5% 99.0%

In the Nasdaq-100 0.0% 49.1%

Holdings 35 25

Top ten, share of the fund 58.5% 73.5%

Expense ratio 0.75% 0.35%

Fee for the differing part 0.76% 0.35%

Total return, 1 year +68.4% +47.2%

vs its benchmark not measured not measured

Below its high −55.5% 0.0%

Net assets, ARKG as of Nov 2, 2026 and BBH as of Nov 3, 2026 $2.1bn $525m

As of Nov 4, 2026. Source: ETFIQ.

12% of the two portfolios are the same securities at the same weight.

Client brief:

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

About each fund

ARKG

By weight, 5% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 58% of the fund across 35 positions, as published by its issuer for Nov 2, 2026. Over the year to Nov 4, 2026 the fund returned +68.4% with distributions reinvested. It sits 55.5% below its all-time high of Jan 20, 2021.

BBH

By weight, 64% of BBH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 74% of the fund across 25 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +47.2% with distributions reinvested.

Questions people ask

Do ARKG and BBH hold the same stocks?: By their latest filings, 12% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, ARKG or BBH?: ARKG has 5% of its weight in S&P 500 names and BBH has 64%, so BBH differs more from the index.
Which is cheaper, ARKG or BBH?: ARKG charges 0.75% a year and BBH charges 0.35%, so BBH is cheaper. Fees come from each fund's prospectus.

Other comparisons

ARKG vs BBC ARKG vs PBE ARKG vs PBPH ARKG vs IBBQ BBH vs IDNA BBH vs GNOM BBH vs GNMX BBH vs FBT

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →ARKG on its own →BBH on its own →ARKG holdings →BBH dividend history →BBH holdings →Method →Standards and sources →

Sources and dates

ARKG filings on SEC EDGAR ↗

ARKG prospectus with the expense ratio (SEC) ↗

ARK page for ARKG ↗

BBH filings on SEC EDGAR ↗

BBH prospectus with the expense ratio (SEC) ↗

VanEck website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, ARKG against BBH, data as of Nov 4, 2026. https://etfiq.com/compare/themes/arkg-vs-bbh

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.